Dr Trust 360 Crosses 2.4 Million Users Following Launch of Advanced AI Health Analytics Suite

Dr Trust 360 Crosses 2.4 Million Users Following Launch of Advanced AI Health Analytics Suite

Dr Trust 360 Crosses 2.4 Million Users Following Launch of Advanced AI Health Analytics Suite​

Nureca Limited, the parent company behind the leading home healthcare brand Dr Trust, has announced that its connected health platform, Dr Trust 360, has surpassed 2.4 million registered users. This significant milestone reflects the increasing demand for tools helping consumers understand and manage their health through home-based monitoring.

Nureca Limited recently launched Dr Trust Intelligence, an advanced AI-powered analytics suite integrated within the Dr Trust 360 app. The new intelligence goes beyond displaying raw biometric readings by interpreting body-composition data in understandable language. It aids users in identifying meaningful trends and helps them determine if their efforts regarding fitness and nutrition are yielding positive results.

Saurabh Goyal, Chairman and Managing Director of Nureca Limited, stated that the user milestone emphasizes the trust Indian families place in the Dr Trust ecosystem. He added that Dr Trust Intelligence is designed not merely to present numbers but to assist users in comprehending what changes are occurring, why those changes matter, and whether their health endeavors are effective.

From Readings to Actionable Guidance​

Dr Trust Intelligence transforms data from compatible 4-electrode and 8-electrode smart body-composition scales into personalized guidance that is easy to understand. The suite provides a comprehensive analysis based on individual history rather than focusing solely on isolated measurements.

Key features of Dr Trust Intelligence include:

  • Plain language interpretation for various body composition metrics, including body fat, muscle mass, and visceral fat.
  • Automatic detection of long-term trends and meaningful changes specific to each user.
  • AI-based diet guidance and personalized recommendations aligned with individual goals and tracked trends.
  • Clear reports designed to support informed conversations with doctors, nutritionists, and fitness professionals.

Advanced Health Monitoring Ecosystem​

The Dr Trust 360 application acts as a unified platform for multiple compatible Dr Trust devices. Users can track body composition data alongside cardiovascular readings and nutrition information within one connected environment, streamlining the process of monitoring changes over time.

A key aspect of the product is its advanced analysis capabilities. Dr Trust's 8-electrode smart scales measure both through the hands and feet, offering a more detailed view of body composition compared to traditional 4-electrode models. Company validation testing indicates up to 98% DEXA-level accuracy for selected metrics such as muscle mass, visceral fat, and body fat.

Data Security and Availability​

Nureca Limited has committed to securing user health data by encrypting and storing it on servers located within India. This infrastructure supports the company's commitment to handling sensitive health records under applicable Indian dataprotection requirements.

Dr Trust Intelligence is available as a premium subscription feature in the Dr Trust 360 app, accessible on both Android and iOS platforms.

Nureca Limited operates as an Indian home healthcare and wellness company and is the parent of several brands, including Dr Trust, Dr Physio, and Trumom. Dr Trust itself is recognized among India's leading home healthcare brands, serving over 1.86 crore customers through its diverse range of devices and connected health solutions.

NURECA Stock Price Movement​

Nureca Limited shares settled higher on Friday, with the equity trading at ₹237.05, reflecting a 0.06% gain on the close. The stock movement was recorded across 5,168 shares, indicating moderate activity during the session.
 

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.

Back
Top